Market Cap 12.64M
Revenue (ttm) 0.00
Net Income (ttm) -27.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 96,170
Avg Vol 591,588
Day's Range N/A - N/A
Shares Out 8.66M
Stochastic %K 12%
Beta 0.22
Analysts Strong Sell
Price Target $15.50

Latest News on MTVA

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Dec 19, 2023, 8:43 AM EST - 1 year ago

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split


NeuroBo to Participate in Investor Conferences in December

Dec 1, 2023, 8:31 AM EST - 1 year ago

NeuroBo to Participate in Investor Conferences in December